By targeting two hormones instead of one, tirzepatide, which is the only dual GLP-1/GIP agonist with FDA approval, has shown an even greater ability than other drugs to help patients lose weight
Clinical studies show that people on Semaglutide often lose about 15% of their body weight over time (when combined with healthy lifestyle choices)
If your glutathione levels are low, it might suggest your body is struggling to keep up with the demands of detoxification or cellular repair
Success on the scale increases a hunger for more success, increasing motivation
They are generally non-refundable after provider review
As a consequence, there has been an unprecedented surge in demand for Ozempic, leading to its off-label prescription for weight loss by physicians, deviating from its original purpose of diabetes management